oldid186169

Teva: Romania is a priority within the group

Teva, leader of the global generics market, targets a 60% turnover growth rate this year, to 16m euros, and a 25% increase in 2009, as part of the aggressive strategy the Israeli group is preparing for Romania. "For Teva, Romania has become a priority, both in...